Sarepta Therapeutics Investor Relations Material
Latest events
Status Update
Sarepta Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Sarepta Therapeutics Inc
Access all reports
Sarepta Therapeutics Inc. is a biopharmaceutical company focused on developing genetic medicines for the treatment of rare diseases. The company specializes in RNA-targeted therapies, gene therapy, and gene editing technologies to address neuromuscular and other genetic disorders. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Sarepta Therapeutics Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Sarepta Therapeutics Inc
Q1 2025
Sarepta Therapeutics Inc
Latest articles
)
Global Doughmination: Breaking Down Domino's Pizza
Inside the rise of Domino's Pizza: how franchising, delivery control, and supply chain mastery built one of the world's most efficient food empires.
18 Jul 2025
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
Ticker symbol
SRPT
Country
🇺🇸 United States